Verified peer comparison
Spero Therapeutics vs GPGI Financial Comparison
Direct answer
Spero Therapeutics and GPGI are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Spero Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Spero Therapeutics Revenue
- 59,619,000 USD
- GPGI Revenue
- 59,824,000 USD
- Spero Therapeutics Operating income
- -24,000 USD
- GPGI Operating income
- -13,731,000 USD